258 related articles for article (PubMed ID: 36473406)
21. Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand.
Lerkvaleekul B; Charuvanij S; Sukharomana M; Pirojsakul K; Kamolwatwong M; Vilaiyuk S
Front Pediatr; 2023; 11():1194821. PubMed ID: 37360372
[TBL] [Abstract][Full Text] [Related]
22. Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study.
Gazitt T; Eviatar T; Shear J; Meidan R; Furer V; Feld J; Haddad A; Elias M; Hijazi N; Stein N; Shaked Mishan P; Zetser A; Peleg H; Elkayam O; Zisman D
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851352
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
McCarter KR; Arabelovic S; Wang X; Wolfgang T; Yoshida K; Qian G; Kowalski EN; Vanni KMM; LeBoeuf NR; Buchbinder EI; Gedmintas L; MacFarlane LA; Rao DA; Shadick NA; Gravallese EM; Sparks JA
Semin Arthritis Rheum; 2024 Feb; 64():152335. PubMed ID: 38100899
[TBL] [Abstract][Full Text] [Related]
24. Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
Kim JW; Jung JY; Suh CH; Ye YM; Kim HA
J Korean Med Sci; 2023 Aug; 38(32):e247. PubMed ID: 37582497
[TBL] [Abstract][Full Text] [Related]
25. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
[TBL] [Abstract][Full Text] [Related]
27. The Use of COVID-19 Vaccines in Patients with SLE.
Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
[TBL] [Abstract][Full Text] [Related]
28. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N; Sen P; Griger Z; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Jan; 63(1):127-139. PubMed ID: 37084267
[TBL] [Abstract][Full Text] [Related]
29. Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity.
Chighizola CB; Suardi I; Carrea G; Argolini L; Gattinara M; Marino A; Pontikaki I; Caporali R; Gerosa M
Rheumatology (Oxford); 2023 Sep; 62(9):3146-3150. PubMed ID: 36702464
[TBL] [Abstract][Full Text] [Related]
30. Should we vaccinate during an active rheumatic disease?
Bijl M; Westra J; Mancuso S; Bearzi P; Giacomelli R; Conti F
Autoimmun Rev; 2024 Jan; 23(1):103426. PubMed ID: 37634680
[TBL] [Abstract][Full Text] [Related]
31. Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
Chen J; Li F; Tian J; Xie X; Tang Q; Chen Y; Ge Y
J Med Virol; 2023 Jan; 95(1):e28307. PubMed ID: 36372774
[TBL] [Abstract][Full Text] [Related]
32. A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia.
Wong PKK; Bagga H; Barrett C; Hanrahan P; Johnson D; Katrib A; Leder K; Marabani M; Pentony P; Riordan J; White R; Young L
Intern Med J; 2017 May; 47(5):491-500. PubMed ID: 28101910
[TBL] [Abstract][Full Text] [Related]
33. New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.
Gasparotto M; Bindoli S; Padoan R; Cozzi G; Depascale R; Zanatta E; Giollo A; Gatto M; Zen M; Schiavon F; Ramonda R; Sfriso P; Doria A; Iaccarino L
Clin Exp Rheumatol; 2023 Mar; 41(3):642-648. PubMed ID: 35930472
[TBL] [Abstract][Full Text] [Related]
34. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
[TBL] [Abstract][Full Text] [Related]
35. Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines.
Dey D; Katso B; Amoako E; Manu A; Bediako Y
BMC Rheumatol; 2024 Jun; 8(1):25. PubMed ID: 38880913
[TBL] [Abstract][Full Text] [Related]
36. Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.
Yoshida T; Tsuji H; Onishi A; Takase Y; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Tanaka M; Yoshifuji H; Morinobu A
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35961691
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus.
Giannopoulou N; Gupta L; Andreoli L; Lini D; ; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
Autoimmun Rev; 2023 Apr; 22(4):103292. PubMed ID: 36740090
[TBL] [Abstract][Full Text] [Related]
39. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.
Furer V; Rondaan C; Heijstek M; van Assen S; Bijl M; Agmon-Levin N; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
RMD Open; 2019; 5(2):e001041. PubMed ID: 31673420
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Farisogullari B; Lawson-Tovey S; Hyrich KL; Gossec L; Carmona L; Strangfeld A; Mateus EF; Schäfer M; Rodrigues A; Hachulla E; Gomez-Puerta JA; Mosca M; Durez P; Trefond L; Goulenok T; Cornalba M; Stenova E; Bulina I; Strakova E; Zepa J; Roux N; Brocq O; Veillard E; Raffeiner B; Burmester GR; Mariette X; Machado PM;
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38816065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
